(ABL) Abacus Life - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00258Y1047

ABL EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of ABL over the last 5 years for every Quarter.

ABL Revenue

This chart shows the Revenue of ABL over the last 5 years for every Quarter.

ABL: Life, Insurance, Policies, Management, Services, Technology

Abacus Global Management, Inc. (NASDAQ:ABL) is a U.S.-based alternative asset manager and market maker specializing in life insurance settlements and related financial services. The company operates through five distinct business segments: Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The Active Management division focuses on acquiring, trading, and holding life insurance policies until death benefits are received. The Originations segment facilitates transactions between investors and policy sellers, often involving the original policyholders. Asset Management provides investment services for alternative assets and equity funds, while Portfolio Servicing delivers policy administration support. The Technology Services division offers real-time solutions for mortality verification and missing participant searches, tailored to the life insurance industry. The company distributes its products through financial advisors, direct-to-consumer channels, and traditional life settlement intermediaries. Formerly known as Abacus Life, Inc., the firm rebranded as Abacus Global Management, Inc. in February 2025. Founded in 2004, it is headquartered in Orlando, Florida.

Based on the provided data, the stock is currently trading at $8.20, with a 20-day moving average of $7.99 and a 200-day moving average of $8.58. The average true range (ATR) of 0.45 indicates moderate volatility. The forward P/E ratio of 10.57 suggests expectations of future earnings growth, while the price-to-book ratio of 1.86 reflects a premium over book value. The negative return on equity (-8.68%) highlights current profitability challenges. Given the technical indicators, the stock may face near-term resistance around the 200-day moving average. However, the forward P/E ratio and market cap of $787.90M suggest investor confidence in the companys growth potential. The low ATR and stable moving averages indicate a relatively calm trading environment, but the negative RoE warrants caution. Overall, the stock is positioned for potential upside, provided the company improves profitability metrics.

Additional Sources for ABL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

ABL Stock Overview

Market Cap in USD 580m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Insurance Brokers
IPO / Inception 2020-09-14

ABL Stock Ratings

Growth Rating -50.3
Fundamental -
Dividend Rating 0.0
Rel. Strength -48.2
Analysts 4.6 of 5
Fair Price Momentum 4.65 USD
Fair Price DCF -

ABL Dividends

Currently no dividends paid

ABL Growth Ratios

Growth Correlation 3m -21.1%
Growth Correlation 12m -71.8%
Growth Correlation 5y -18.3%
CAGR 5y -11.66%
CAGR/Max DD 5y -0.21
Sharpe Ratio 12m -0.82
Alpha -46.72
Beta 0.689
Volatility 95.31%
Current Volume 1118.7k
Average Volume 20d 1239.4k
What is the price of ABL shares?
As of June 24, 2025, the stock is trading at USD 5.45 with a total of 1,118,663 shares traded.
Over the past week, the price has changed by -10.21%, over one month by -33.29%, over three months by -27.53% and over the past year by -35.96%.
Is Abacus Life a good stock to buy?
No, based on ValueRay´s Analyses, Abacus Life (NASDAQ:ABL) is currently (June 2025) a stock to sell. It has a ValueRay Growth Rating of -50.34 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ABL is around 4.65 USD . This means that ABL is currently overvalued and has a potential downside of -14.68%.
Is ABL a buy, sell or hold?
Abacus Life has received a consensus analysts rating of 4.60. Therefor, it is recommend to buy ABL.
  • Strong Buy: 3
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for ABL share price target?
According to our own proprietary Forecast Model, ABL Abacus Life will be worth about 5.1 in June 2026. The stock is currently trading at 5.45. This means that the stock has a potential downside of -6.79%.
Issuer Target Up/Down from current
Wallstreet Target Price 13.7 151.4%
Analysts Target Price 13.7 151.4%
ValueRay Target Price 5.1 -6.8%